United Kingdom Myeloma Forum (UKMF) position statement on the use of bendamustine in myeloma.
about
Bendamustine in multiple myeloma.Optimal use of bendamustine in hematologic disorders: Treatment recommendations from an international consensus panel - an updateBendamustine hydrochloride in patients with B-cell malignancies who have comorbidities - is there an optimal dose?Bendamustine, Low-dose dexamethasone, and lenalidomide (BdL) for the treatment of patients with relapsed/refractory multiple myeloma confirms very promising results in a phase I/II study.
P2860
United Kingdom Myeloma Forum (UKMF) position statement on the use of bendamustine in myeloma.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
United Kingdom Myeloma Forum ( ...... se of bendamustine in myeloma.
@en
United Kingdom Myeloma Forum
@nl
type
label
United Kingdom Myeloma Forum ( ...... se of bendamustine in myeloma.
@en
United Kingdom Myeloma Forum
@nl
prefLabel
United Kingdom Myeloma Forum ( ...... se of bendamustine in myeloma.
@en
United Kingdom Myeloma Forum
@nl
P2093
P2860
P356
P1476
United Kingdom Myeloma Forum ( ...... use of bendamustine in myeloma
@en
P2093
J A Snowden
J Cavenagh
P2860
P356
10.1111/IJLH.12097
P577
2013-04-25T00:00:00Z